Physician Assistant Program year 2023 Reported 2021–2023 Source: CMS Open Payments, 2026 publication

Elisa Gomez

Physician Assistant Mooresville, NC Physician Assistant

NPI 1235723958 CMS profile 11151590

146 Medical Park Rd Ste 106, Mooresville, NC 28117

Open in the dashboard

General payments

$4,211

226 records reported · program years 2021–2023

Research payments

$0

Paid to them · None reported · program years 2021–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Elisa Gomez of Mooresville, NC is reported in the CMS Open Payments database as having received $4,211 across 226 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $270 16
2022 General $1,880 113
2021 General $2,062 97

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Elisa Gomez
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Elisa Gomez were reported at $0. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Elisa Gomez Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $2,062 $132 $37–$438 $132
2022 $1,880 $155 $48–$522 $149
2023 $270 $167 $52–$557 $160
2024 $0 $178 $55–$600 $164
2025 $0 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2023
  1. AbbVie, Inc. $904 50 payments
  2. Teva Pharmaceuticals USA, Inc. $575 25 payments
  3. Otsuka America Pharmaceutical, Inc. $461 23 payments
  4. Alkermes, Inc. $443 19 payments
  5. ITI, Inc. $412 18 payments
  6. Takeda Pharmaceuticals U.S.A., Inc. $271 21 payments
  7. Neurocrine Biosciences, Inc. $225 15 payments
  8. Lundbeck LLC $196 15 payments
  9. Sunovion Pharmaceuticals Inc. $166 5 payments
  10. Supernus Pharmaceuticals, Inc. $133 8 payments
  11. Other $427 27 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2023
  1. Food and Beverage $4,110 223 payments
  2. Education $101 3 payments
Products named General payments · program years 2021–2023
  1. VRAYLAR $904 50 payments
  2. AUSTEDO $489 24 payments
  3. LYBALVI Cns $430 18 payments
  4. LYBALVI Cns $430 18 payments
  5. CAPLYTA $412 18 payments
  6. REXULTI $309 11 payments
  7. TRINTELLIX $235 19 payments
  8. LYBALVI Cns $224 2 payments
  9. LYBALVI Cns $224 2 payments
  10. ARISTADA INITIO $218 17 payments
  11. Other $1,830 123 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 11 billing codes

Paid by Medicare

$12,690

Medicare's payments for the services billed

Medicare patients

124

Average age 75

Services billed

151

57 women, 67 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 49%
Chronic kidney disease 44%
Ischemic heart disease 42%
Diabetes 41%
Depression 41%
Atrial fibrillation 40%
Alzheimer's or dementia 38%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

226 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record